GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 381 filers reported holding GUARDANT HEALTH INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,038,033 | -17.2% | 676,047 | 0.0% | 18.92% | +15.8% |
| Q2 2023 | $24,202,483 | +110.5% | 676,047 | +37.8% | 16.34% | +114.9% |
| Q1 2023 | $11,496,031 | -51.3% | 490,445 | -43.5% | 7.60% | -52.1% |
| Q4 2022 | $23,621,704 | -55.2% | 868,445 | -11.2% | 15.87% | -25.4% |
| Q3 2022 | $52,670,000 | +56.5% | 978,445 | +17.3% | 21.26% | +16.3% |
| Q2 2022 | $33,649,000 | -23.2% | 834,145 | +26.1% | 18.28% | -12.1% |
| Q1 2022 | $43,814,000 | +12.1% | 661,445 | +69.2% | 20.79% | +73.8% |
| Q4 2021 | $39,102,000 | +146.6% | 390,945 | +208.3% | 11.96% | +131.9% |
| Q3 2021 | $15,854,000 | -44.6% | 126,824 | -45.0% | 5.16% | -52.1% |
| Q2 2021 | $28,637,000 | +1.2% | 230,595 | +24.4% | 10.78% | -22.0% |
| Q1 2021 | $28,290,000 | -22.1% | 185,330 | -34.2% | 13.82% | +27.7% |
| Q4 2020 | $36,318,000 | – | 281,800 | – | 10.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |